ETF1

Eukaryotic peptide chain release factor subunit 1 · P62495 · ETF1 on Sugi Atlas →

0 patent compounds predicted against ETF1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ETF1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Use of Essential Oils as Natural Therapies PHASE3COMPLETED
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study PHASE2COMPLETED
Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients PHASE1/PHASE2WITHDRAWN
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia PHASE1/PHASE2WITHDRAWN
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas PHASE2COMPLETED
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis PHASE1/PHASE2WITHDRAWN
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma PHASE2UNKNOWN
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Clubfoot DNA Repository nanCOMPLETED
IL-17 Role in Variants of Psoriasis nanCOMPLETED
Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking* nanCOMPLETED
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy. nanCOMPLETED
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Biobanking of Rett Syndrome and Related Disorders nanCOMPLETED
Genetics of Rheumatoid Arthritis nanCOMPLETED
Family Study of Melanoma in Italy nanCOMPLETED
Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurodevelopmental Disorders nanCOMPLETED
Study of Systemic Amyloidosis Presentation and Prognosis nanUNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Genetic Analysis of Familial Melanoma nanCOMPLETED
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives nanCOMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study nanCOMPLETED
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients nanCOMPLETED
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ETF1 binder may also engage these)

ProteinNameSimilarity
P62498 1.000 P62498 →
P35615 1.000 P35615 →
Q9GR88 1.000 Q9GR88 →
Q5U2Q7 0.999 Q5U2Q7 →
Q8BWY3 0.999 Q8BWY3 →
P62497 0.999 P62497 →
Q5R4C7 0.997 Q5R4C7 →
P62496 0.997 P62496 →
Q0VCX5 0.997 Q0VCX5 →
D2K759 0.995 D2K759 →
Q9VPH7 0.989 Q9VPH7 →
Q9LPV8 0.987 Q9LPV8 →
P35614 0.985 P35614 →
D2K760 0.984 D2K760 →
Q39097 0.978 Q39097 →
D5LHJ0 0.977 D5LHJ0 →
GNPDA1 Glucosamine-6-phosphate deaminase 1 0.945 landscape →
Q8LPJ4 0.941 Q8LPJ4 →
Q01405 0.941 Q01405 →
Q4R5J0 0.940 Q4R5J0 →
Q64422 0.939 Q64422 →
Q5ZJL4 0.938 Q5ZJL4 →
A2VDL8 0.938 A2VDL8 →
Q6Q7J2 0.938 Q6Q7J2 →
Q9H2P9 0.937 Q9H2P9 →
Q9NQL2 0.937 Q9NQL2 →
O59948 0.937 O59948 →
P60028 0.936 P60028 →
Q90YX1 0.936 Q90YX1 →
Q1JQA3 0.936 Q1JQA3 →